BioLargo CEO Dennis Calvert joined Proactive's Natalie Stoberman to share more details of the addition of Nicholas Valeriani and Linda Park to the board of directors of subsidiary Clyra Medical Technologies.
BioLargo noted that Valeriani has decades of executive experience in the medical device industry. He spent 34 years at Johnson & Johnson, where he led several corporate functions and was a member of its executive committee.
Park is a trusted executive and legal professional with a proven track record of supporting and advising public companies at the corporate board and executive level at billion-dollar corporations.
Proactive USA
+1 347-449-0879
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$0.29 |
Daily Change: | -0.0065 -2.22 |
Daily Volume: | 638,026 |
Market Cap: | US$82.800M |
June 12, 2024 June 11, 2024 May 14, 2024 April 02, 2024 |
LithiumBank Resources is creating an opportunity to participate in the future of clean-tech energy. The company's strategy is to acquire claims in known lithium high grade hot spots with existing wells and infrastructure...
CLICK TO LEARN MOREPond Technologies has developed a proprietary system that can profitably transform CO2 into valuable products. The company's carbon business focuses on absorbing greenhouse gas emissions, transforming these into...
CLICK TO LEARN MORECOPYRIGHT ©2022 GREEN STOCK NEWS